Publicacións en colaboración con investigadores/as de Boston University (1)

2010

  1. Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: Safety, pharmacokinetics, and pharmacodynamics

    Molecular Cancer Therapeutics, Vol. 9, Núm. 10, pp. 2844-2852